Wild Mountain Time” is a Visitor Quest that unlocks after Poco has reached a 5 Star Rating in Hello Kitty Island Adventure.

Managing your emails and to-do list doesn't have to involve an overly-complicated strategy—try using the yesterbox inbox ...

Law Prep Tutorial secures AIR-1 in both CLAT 2026 and AILET 2026. An inside look at the systems, mentorship, mock strategy, and performance-led preparation behind this historic result.

Abstract: Multiple access (MA) is a crucial part of any wireless system and refers to techniques that make use of the resource dimensions (e.g., time, frequency, power, antenna, code, and message) to ...

Cold weather has come early to many parts of the country as Environment Canada released its winter outlook for the coming months. After a “remarkably mild” fall almost everywhere in Canada, the ...

Losing your phone can leave you in panic mode, especially when the battery dies. The good news is that both Apple and Android offer built-in tools that help you track a missing device even when it is ...

Forbes contributors publish independent expert analyses and insights. Davey Winder is a veteran cybersecurity writer, hacker and analyst. A newly published threat intelligence report by analysts at ...

The AI-powered ‘Help me schedule’ feature will use the context of your email and your Google Calendar to help find available time slots. The AI-powered ‘Help me schedule’ feature will use the context ...

APT28, the state-sponsored threat group tied to Russian intelligence, is weaponizing Microsoft Outlook through a new backdoor researchers call "NotDoor." The backdoor malware was first identified by ...

The agency issued a complete response letter (CRL) to its biologics license application (BLA) resubmission, indicating that the FDA cannot approve the application in its present form for the treatment ...

Outlook Therapeutics’ second attempt to market an ophthalmic version of Roche’s tried-and-true Avastin in the U.S. has been knocked back by the FDA. In a new complete response letter, the FDA has ...